References
- IaconoPParodiMBFalcomataBBandelloFCentral serous chorioretinopathy treatments: a mini reviewOphthalmic Res20165527684
- LevineRBruckerAJRobinsonFLong-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiographyOphthalmology19899668548592740080
- NicholsonBNobleJForooghianFMeyerleCCentral serous chorioretinopathy: update on pathophysiology and treatmentSurv Ophthalmol201358210312623410821
- FungATYannuzziLAFreundKBType 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degenerationRetina20123291829183722850219
- DaruichAMatetADiraniACentral serous chorioretinopathy: recent findings and new physiopathology hypothesisProg Retin Eye Res2015488211826026923
- ChanWMLaiTYLaiRYLiuDTLamDSHalf-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trialOphthalmology2008115101756176518538401
- ReibaldiMBosciaFAvitabileTLow-fluence photodynamic therapy in longstanding chronic central serous chorioretinopathy with foveal and gravitational atrophyEur J Ophthalmol200919115415819123167
- MaJMengNXuXZhouFQuYSystem review and meta-analysis on photodynamic therapy in central serous chorioretinopathyActa Ophthalmol2014928e594e60125042260
- MehanySShaukatAMMohamedFSMouradKMRole of Avastin in management of central serous chorioretinopathySaudi J Ophthalmol2010243697523960879
- ChungYRSeoEJLewHMLeeKHLack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and reviewEye201327121339134624202051
- KurtzDCarlsonNBClinical Procedures of Ocular Examination3rd editionNew YorkMcGraw-Hill2003
- WangMSSanderBLarsenMRetinal atrophy in idiopathic central serous chorioretinopathyAm J Ophthalmol2002133678779312036670
- SpaideRFCampeasLHaasACentral serous chorioretinopathy in younger and older adultsOphthalmology199610312207020799003341
- ErikitolaOCCrosby-NwaobiRLoteryAJSivaprasadSPhotodynamic therapy for central serous chorioretinopathyEye (Lond)201428894495724946843
- LeePYKimKSLeeWKSevere choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathyJpn J Ophthalmol2009531525619184311
- NicoloMEandiCMAlovisiCHalf-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathyAm J Ophthalmol201415751033103724487046
- RouvasAStavarkasPTheodossiadisPGLong-term results of half-fluence photodynamic therapy for chronic central serous chorioretinopathyEur J Ophthalmol201222341742221928269
- LaiTYYWongRLMChanWLong-term outcomes of half-dose verteporfin photodynamic therapy for the treatment of central serous chorioretinopathy (An American Ophthalmological Society Thesis)Trans Am Ophthalmol Soc2015113T826755855
- InoueMKadanosonoKWatanabeYKobayashiSYamaneSArakawaAResults of one-year follow-up examinations after intravitreal bevacizumab administration for chronic central serous chorioretinopathyOphthalmologica20112251374020693820
- SmretschnigEHagenSGlittenbergCIntravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathyEye (Lond)201630680581126965012
- XuYTanCSSafety and complications of intravitreal injections performed in an Asian population in SingaporeInt Ophthalmol201637232533227236451
- UetaniRItoYOiwaKIshikawaKTeriyakiHHalf dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathyEye (Lond)201226564064922573069